Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation, Restricted Stock and Stock Options: (Details) - Schedule of stock options

v3.21.2
Stock-Based Compensation, Restricted Stock and Stock Options: (Details) - Schedule of stock options - Stock Options [Member] - USD ($)
 12 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Stock-Based Compensation, Restricted Stock and Stock Options: (Details) - Schedule of stock options [Line Items]    
Shares Underlying Options Outstanding 1,937,833 1,937,833
Weighted Average Exercise Price Outstanding $ 0.54 $ 0.54
Weighted Average Remaining Contractual Term (Years) Outstanding 8 years 73 days 9 years 73 days
Aggregate Intrinsic Value Outstanding $ 4,243,610 $ 3,720,395
Shares Underlying Options Outstanding 10,861,940 1,937,833
Weighted Average Exercise Price Outstanding $ 2.73 $ 0.54
Weighted Average Remaining Contractual Term (Years) Outstanding 8 years  
Aggregate Intrinsic Value Outstanding $ 17,523,650 $ 4,243,610
Shares Underlying Options Exercisable 10,382,079  
Weighted Average Exercise Price Exercisable $ 2.64  
Weighted Average Remaining Contractual Term (Years) Exercisable 8 years  
Aggregate Intrinsic Value Exercisable $ 17,361,817  
Shares Underlying Options Granted 8,949,107  
Weighted Average Exercise Price Granted $ 3.23  
Weighted Average Remaining Contractual Term (Years) Granted 8 years 146 days  
Shares Underlying Options Exercised (25,000)  
Weighted Average Exercise Price Exercised $ 0.15